首页> 外文期刊>JACC. Cardiovascular interventions >Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 mg Clopidogrel Versus 60 mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention The ETAMI Trial (Early Thienopyridine treatment to improve primary PCI in Patients with Acute Myocardial Infarction)
【24h】

Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 mg Clopidogrel Versus 60 mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention The ETAMI Trial (Early Thienopyridine treatment to improve primary PCI in Patients with Acute Myocardial Infarction)

机译:加载剂量的双盲,随机,前瞻性比较600毫克氯吡格雷对60毫克普拉斯患者急性急性ST段升高的患者,预定用于初步经皮干预的埃塞米试验(早期噻吩吡啶治疗,以改善急性心肌患者的原发性PCI 梗塞)

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES This study compared the timing of onset of antiplatelet action after treatment with clopidogrel and prasugrel at first medical contact in patients with ST-segment elevation myocardial infarction (STEMI) scheduled for primary percutaneous coronary intervention (PPCI).
机译:目的这项研究比较了在患有ST段抬高心肌梗死(STEMI)的氯吡格雷和普拉布雷治疗后抗血小板和普拉塞尔治疗后的抗血小板动作的时序进行比较,该术治疗初级经皮冠状动脉介入(PPCI)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号